106 related articles for article (PubMed ID: 11455580)
1. Three-dimensional structural analysis of fibronectin heparin-binding domain mutations.
Kapila Y; Doan D; Tafolla E; Fletterick R
J Cell Biochem Suppl; 2001; Suppl 36():156-61. PubMed ID: 11455580
[TBL] [Abstract][Full Text] [Related]
2. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle.
Busby TF; Argraves WS; Brew SA; Pechik I; Gilliland GL; Ingham KC
J Biol Chem; 1995 Aug; 270(31):18558-62. PubMed ID: 7629186
[TBL] [Abstract][Full Text] [Related]
3. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
[TBL] [Abstract][Full Text] [Related]
4. The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site.
Zhong X; Arnolds O; Krenczyk O; Gajewski J; Pütz S; Herrmann C; Stoll R
Biochemistry; 2018 Oct; 57(42):6045-6049. PubMed ID: 30260627
[TBL] [Abstract][Full Text] [Related]
5. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X.
Lethias C; Elefteriou F; Parsiegla G; Exposito JY; Garrone R
J Biol Chem; 2001 May; 276(19):16432-8. PubMed ID: 11278641
[TBL] [Abstract][Full Text] [Related]
7. Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin.
Sachchidanand ; Lequin O; Staunton D; Mulloy B; Forster MJ; Yoshida K; Campbell ID
J Biol Chem; 2002 Dec; 277(52):50629-35. PubMed ID: 12377765
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the NH2-terminal domain of fibronectin with heparin. Role of the omega-loops of the type I modules.
Kishore R; Samuel M; Khan MY; Hand J; Frenz DA; Newman SA
J Biol Chem; 1997 Jul; 272(27):17078-85. PubMed ID: 9202024
[TBL] [Abstract][Full Text] [Related]
9. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
10. The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro.
Kapila YL; Niu J; Johnson PW
J Biol Chem; 1997 Jul; 272(30):18932-8. PubMed ID: 9228073
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C binds heparin by its fibronectin type III domain five.
Weber P; Zimmermann DR; Winterhalter KH; Vaughan L
J Biol Chem; 1995 Mar; 270(9):4619-23. PubMed ID: 7533163
[TBL] [Abstract][Full Text] [Related]
12. Localization of the major heparin-binding site in fibronectin.
Barkalow FJ; Schwarzbauer JE
J Biol Chem; 1991 Apr; 266(12):7812-8. PubMed ID: 2019604
[TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A
Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a heparin- and integrin-binding segment of human fibronectin.
Sharma A; Askari JA; Humphries MJ; Jones EY; Stuart DI
EMBO J; 1999 Mar; 18(6):1468-79. PubMed ID: 10075919
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading.
Santas AJ; Peterson JA; Halbleib JL; Craig SE; Humphries MJ; Peters DM
J Biol Chem; 2002 Apr; 277(16):13650-8. PubMed ID: 11832485
[TBL] [Abstract][Full Text] [Related]
16. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin.
Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL
Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain.
Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L
Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants.
Mostafavi-Pour Z; Askari JA; Whittard JD; Humphries MJ
Matrix Biol; 2001 Feb; 20(1):63-73. PubMed ID: 11246004
[TBL] [Abstract][Full Text] [Related]
19. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism.
Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M
Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain.
Pickford AR; Potts JR; Bright JR; Phan I; Campbell ID
Structure; 1997 Mar; 5(3):359-70. PubMed ID: 9083105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
